Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E: Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila). 2014, 7: 867-885. 10.1158/1940-6207.CAPR-13-0424.
Article
CAS
Google Scholar
Mihaylova MM, Shaw RJ: The AMPKsignalling pathway coordinates cell growth, autophagy, and metabolism. Nat Cell Bio. 2011, 13: 1016-1023. 10.1038/ncb2329.
Article
CAS
Google Scholar
Hardie DG, Alessi DR: LKB1 and AMPK and the cancer-metabolism link - ten years after. BMC Biol. 2013, 11: 36-10.1186/1741-7007-11-36.
Article
PubMed Central
PubMed
Google Scholar
Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F, Viollet B: Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010, 120: 2355-2369. 10.1172/JCI40671.
Article
CAS
PubMed Central
PubMed
Google Scholar
Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ: Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013, 494: 256-260. 10.1038/nature11808.
Article
CAS
PubMed Central
PubMed
Google Scholar
Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, Jurczak MJ, Camporez JP, Lee HY, Cline GW, Samuel VT, Kibbey RG, Shulman GI: Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014, 510: 542-546. 10.1038/nature13270.
Article
CAS
PubMed Central
PubMed
Google Scholar
Pollak MN: Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov. 2012, 2: 778-790. 10.1158/2159-8290.CD-12-0263.
Article
CAS
PubMed
Google Scholar
Shackelford DB, Abt E, Gerken L, Vasquez DS, Seki A, Leblanc M, Wei L, Fishbein MC, Czernin J, Mischel PS, Shaw RJ: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell. 2013, 23: 143-158. 10.1016/j.ccr.2012.12.008.
Article
CAS
PubMed Central
PubMed
Google Scholar
Andrzejewski S, Gravel SP, Pollak M, St-Pierre J: Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab. 2014, 2: 12-10.1186/2049-3002-2-12.
Article
PubMed Central
PubMed
Google Scholar
Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, Rajagopalan KN, Maddie M, Vemireddy V, Zhao Z, Cai L, Good L, Tu BP, Hatanpaa KJ, Mickey BE, Matés JM, Pascual JM, Maher EA, Malloy CR, Deberardinis RJ, Bachoo RM: Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 2012, 15: 827-837. 10.1016/j.cmet.2012.05.001.
Article
CAS
PubMed Central
PubMed
Google Scholar
Semenza GL: HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest. 2013, 123: 3664-3671. 10.1172/JCI67230.
Article
CAS
PubMed Central
PubMed
Google Scholar
Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budinger GS, Chandel NS: Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife. 2014, 3: e02242-10.7554/eLife.02242.
Article
PubMed Central
PubMed
Google Scholar
Tomimoto A, Endo H, Sugiyama M, Fujisawa T, Hosono K, Takahashi H, Nakajima N, Nagashima Y, Wada K, Nakagama H, Nakajima A: Metformin suppresses intestinal polyp growth in ApcMin/+mice. Cancer Sci. 2008, 99: 2136-2141. 10.1111/j.1349-7006.2008.00933.x.
Article
CAS
PubMed
Google Scholar